New pill shows promise in reducing pain crises for sickle cell patients
Disease control
Completed
This study tested an oral medication called epeleuton in 35 adults with sickle cell disease. The goal was to see how the drug moves through the body, how it affects blood cells, and if it can reduce painful vaso-occlusive crises. Participants took the drug for 16 weeks, and resea…
Phase: PHASE2 • Sponsor: Afimmune • Aim: Disease control
Last updated May 07, 2026 18:43 UTC